Profound Medical Corp (PROF)
7.37
-0.13
(-1.73%)
USD |
NASDAQ |
May 31, 16:00
7.48
+0.11
(+1.49%)
After-Hours: 20:00
Profound Medical Enterprise Value: 145.34M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 145.34M |
| May 30, 2024 | 148.52M |
| May 29, 2024 | 144.37M |
| May 28, 2024 | 144.85M |
| May 24, 2024 | 143.88M |
| May 23, 2024 | 146.56M |
| May 22, 2024 | 158.29M |
| May 21, 2024 | 164.03M |
| May 20, 2024 | 166.60M |
| May 17, 2024 | 167.82M |
| May 16, 2024 | 172.58M |
| May 15, 2024 | 173.92M |
| May 14, 2024 | 165.86M |
| May 13, 2024 | 152.18M |
| May 10, 2024 | 154.14M |
| May 09, 2024 | 173.44M |
| May 08, 2024 | 148.52M |
| May 07, 2024 | 146.32M |
| May 06, 2024 | 146.44M |
| May 03, 2024 | 145.10M |
| May 02, 2024 | 144.85M |
| May 01, 2024 | 147.30M |
| April 30, 2024 | 147.05M |
| April 29, 2024 | 153.40M |
| April 26, 2024 | 161.47M |
| Date | Value |
|---|---|
| April 25, 2024 | 161.47M |
| April 24, 2024 | 160.49M |
| April 23, 2024 | 153.40M |
| April 22, 2024 | 154.87M |
| April 19, 2024 | 154.63M |
| April 18, 2024 | 156.82M |
| April 17, 2024 | 155.73M |
| April 16, 2024 | 156.09M |
| April 15, 2024 | 158.29M |
| April 12, 2024 | 158.78M |
| April 11, 2024 | 168.06M |
| April 10, 2024 | 160.73M |
| April 09, 2024 | 163.91M |
| April 08, 2024 | 168.31M |
| April 05, 2024 | 161.95M |
| April 04, 2024 | 165.86M |
| April 03, 2024 | 170.50M |
| April 02, 2024 | 170.75M |
| April 01, 2024 | 167.33M |
| March 31, 2024 | 173.68M |
| March 28, 2024 | 189.27M |
| March 27, 2024 | 183.16M |
| March 26, 2024 | 179.99M |
| March 25, 2024 | 179.01M |
| March 22, 2024 | 182.43M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
20.18M
Minimum
Oct 26 2022
483.76M
Maximum
Feb 05 2021
182.39M
Average
172.98M
Median
Enterprise Value Benchmarks
| Delcath Systems Inc | 176.13M |
| Star Equity Holdings Inc | 14.38M |
| Exact Sciences Corp | 10.10B |
| CytoSorbents Corp | 44.70M |
| Progyny Inc | 2.194B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.199M |
| Revenue (Quarterly) | 1.91M |
| Total Expenses (Quarterly) | 9.392M |
| EPS Diluted (Quarterly) | -0.26 |
| Gross Profit Margin (Quarterly) | 66.44% |
| Profit Margin (Quarterly) | -324.6% |
| Earnings Yield | -17.50% |
| Normalized Earnings Yield | -17.05 |